16:35:14 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



Allkem Ltd
Symbol AKE
Shares Issued 637,525,586
Close 2023-12-21 C$ 8.86
Market Cap C$ 5,648,476,692
Recent Sedar Documents

Allkem, Livent receive court approval for merger

2023-12-21 03:11 ET - News Release

Mr. Andrew Barber reports

RESULTS OF SECOND COURT HEARING

Allkem Ltd. has referred to the proposed merger of equals between Allkem and Livent Corp.

Allkem is pleased to announce that the Federal Court of Australia made orders today, approving the proposed scheme of arrangement pursuant to which Arcadium Lithium PLC will acquire 100 per cent of the shares in Allkem in connection with the transaction.

Lodgment of court orders and suspension of trading

Allkem expects to lodge an office copy of the court's orders with the Australian Securities and Investments Commission tomorrow, Dec. 21, 2023, at which time the scheme will become legally effective.

If this occurs, Allkem expects that Allkem shares will be suspended from trading on the Australian Securities Exchange at the close of trading on Dec. 21, 2023, Australian Eastern Daylight Time, and on the Toronto Stock Exchange at 4 p.m. Toronto time on Dec. 21, 2023.

Quotation and trading of scheme consideration

Arcadium Lithium CDIs are expected to commence trading on the ASX on a deferred settlement basis on Dec. 22, 2023, and on a normal (T plus 2) settlement basis on Jan. 5, 2024 (1).

Arcadium Lithium shares are expected to commence trading on the New York Stock Exchange on Jan. 4, 2023.

Scheme timetable

The key remaining dates expected for the transaction are set out herein.

All dates are indicative only, and Allkem reserves the right to vary the times and dates set out herein. Any changes to the timetable will be announced through the ASX, filed under Allkem's profile on SEDAR+ and notified on the Allkem website.

(1) It is the responsibility of Allkem shareholders who will receive Arcadium Lithium CDIs under the scheme to confirm their holdings of Arcadium Lithium CDIs before they trade them. Allkem shareholders who sell Arcadium Lithium CDIs before they receive their holding statements or confirm their holdings do so at their own risk. Further details in relation to deferred settlement trading of Arcadium Lithium CDIs are set out in the scheme booklet.

© 2024 Canjex Publishing Ltd. All rights reserved.